Literature DB >> 23164512

The incidence of "silent" free air and aspiration pneumonia detected by CT after gastric endoscopic submucosal dissection.

Jiro Watari1, Toshihiko Tomita, Fumihiko Toyoshima, Jun Sakurai, Takashi Kondo, Haruki Asano, Takahisa Yamasaki, Takuya Okugawa, Junji Tanaka, Takashi Daimon, Tadayuki Oshima, Hirokazu Fukui, Kazutoshi Hori, Takayuki Matsumoto, Hiroto Miwa.   

Abstract

BACKGROUND: Although endoscopic submucosal dissection (ESD) is feasible as a treatment for early gastric cancer, it requires great skill to perform and may place patients at increased risk of a number of complications, including perforation and aspiration pneumonia.
OBJECTIVE: To investigate the incidence of "silent" free air without endoscopic perforation and aspiration pneumonia detected by CT after ESD and risk factors for the development of these 2 conditions.
DESIGN: Prospective cohort study.
SETTING: Single academic center. PATIENTS: This study involved 87 patients with a total of 91 malignancies. INTERVENTION: All patients underwent chest and abdominal CT and blood biochemistry analysis before and 1 day after ESD. MAIN OUTCOME MEASUREMENTS: The incidence of silent free air and aspiration pneumonia after ESD and the related risk factors.
RESULTS: Silent free air was identified in 37.3% of patients without perforation. Tumor location (the upper portion of the stomach), the presence of a damaged muscular layer during ESD, and procedure time, but not specimen size, were significantly associated with silent free air (P = .006, P = .04, P = .02, and P = .53, respectively). According to the receiver-operating characteristic analysis, the resulting cutoff value of the procedure time for silent free air was 105 minutes (67.7% sensitivity, 65.4% specificity). Only procedure time (≥ 105 minutes) was an independent predictor of silent free air development (odds ratio 3.23; 95% confidence interval, 1.21-8.64; P = .02). On the other hand, aspiration pneumonia was seen in 6.6% of patients. Silent free air and aspiration pneumonia did not affect hospitalization. LIMITATIONS: Single center and small number of patients.
CONCLUSIONS: Silent free air is frequently observed after ESD, and longer procedure time (≥ 105 minutes) was an independent risk factor for silent free air. However, silent free air and aspiration pneumonia detected by CT are not associated with clinically significant complications.
Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23164512     DOI: 10.1016/j.gie.2012.07.043

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  16 in total

1.  Efficacy and safety of endoscopic submucosal dissection under general anesthesia.

Authors:  Kanefumi Yamashita; Hironari Shiwaku; Toshihiro Ohmiya; Hideki Shimaoka; Hiroki Okada; Ryo Nakashima; Richiko Beppu; Daisuke Kato; Takamitsu Sasaki; Seiichiro Hoshino; Satoshi Nimura; Ken Yamaura; Yuichi Yamashita
Journal:  World J Gastrointest Endosc       Date:  2016-07-10

2.  Risk Factors for Aspiration Pneumonia After Endoscopic Hemostasis.

Authors:  Koki Kawanishi; Jun Kato; Nobuo Toda; Mari Yamagami; Tomoharu Yamada; Kentaro Kojima; Takamasa Ohki; Michiharu Seki; Kazumi Tagawa
Journal:  Dig Dis Sci       Date:  2015-10-30       Impact factor: 3.199

3.  Clinical significance of intraperitoneal air on computed tomography scan after endoscopic submucosal dissection in patients with gastric neoplasms.

Authors:  Soo-Jeong Cho; Il Ju Choi; Soo Jin Kim; Min Ju Kim; Chan Gyoo Kim; Jong Yeul Lee; Keun Won Ryu; Young-Woo Kim
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

4.  Pneumonia after endoscopic resection for gastric neoplasm.

Authors:  Eun Jeong Gong; Do Hoon Kim; Hwoon-Yong Jung; Hyun Lim; Ji Yong Ahn; Kwi-Sook Choi; Jeong Hoon Lee; Kee Don Choi; Ho June Song; Gin Hyug Lee; Jin-Ho Kim; Seunghee Baek
Journal:  Dig Dis Sci       Date:  2014-07-15       Impact factor: 3.199

5.  Outcomes of patients with early gastric cancer who underwent double endoscopic intraluminal surgery.

Authors:  Yoshitaka Toyomasu; Masaki Suzuki; Toru Yanoma; Akiharu Kimura; Norimichi Kogure; Kyoichi Ogata; Tetsuro Ohno; Erito Mochiki; Hiroyuki Kuwano
Journal:  Surg Endosc       Date:  2015-04-01       Impact factor: 4.584

6.  Preoperative Pulmonary Function Tests Predict Aspiration Pneumonia After Gastric Endoscopic Submucosal Dissection.

Authors:  Akihiro Matsumi; Ryuta Takenaka; Chihiro Ando; Yuki Sato; Kensuke Takei; Eriko Yasutomi; Shotaro Okanoue; Shohei Oka; Daisuke Kawai; Junro Kataoka; Koji Takemoto; Hirofumi Tsugeno; Shigeatsu Fujiki; Yoshiro Kawahara
Journal:  Dig Dis Sci       Date:  2017-09-06       Impact factor: 3.199

Review 7.  Updated evidence on endoscopic resection of early gastric cancer from Japan.

Authors:  Mitsuhiro Fujishiro; Shuntaro Yoshida; Rie Matsuda; Akiko Narita; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Gastric Cancer       Date:  2016-10-04       Impact factor: 7.370

8.  The usage of overtube has a favorable effect on endoscopic submucosal dissection.

Authors:  Fatih Aslan; Ali Rıza Seren; Zehra Akpinar; Aylin Cakir Guven; Nese Ekinci; Emrah Alper; Cem Cekic; Belkis Unsal; Hironori Yamamoto
Journal:  Surg Endosc       Date:  2014-11-27       Impact factor: 4.584

9.  Clinical outcomes and risk factors for perforation in gastric endoscopic submucosal dissection: A prospective pilot study.

Authors:  Jiro Watari; Toshihiko Tomita; Fumihiko Toyoshima; Jun Sakurai; Takashi Kondo; Haruki Asano; Takahisa Yamasaki; Takuya Okugawa; Hisatomo Ikehara; Tadayuki Oshima; Hirokazu Fukui; Hiroto Miwa
Journal:  World J Gastrointest Endosc       Date:  2013-06-16

10.  Risk factors for pyrexia after endoscopic submucosal dissection of gastric lesions.

Authors:  Takayuki Nakanishi; Hiroshi Araki; Noritaka Ozawa; Jun Takada; Masaya Kubota; Kenji Imai; Fumito Onogi; Takashi Ibuka; Makoto Shiraki; Masahito Shimizu; Hisataka Moriwaki
Journal:  Endosc Int Open       Date:  2014-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.